Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valacyclovir for VZV-Associated Achalasia
NCT05550194Phase 4Recruiting
- Sponsor
- Vanderbilt University Medical Center
- Start
- Mar 2023
- Primary completion
- Aug 2027
- Modality
- Metabolically Activated Prodrugs, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of valaciclovir in achalasia, sponsored by Vanderbilt University Medical Center. Started Mar 2023; status: recruiting.
02
Drugs
valaciclovir
03
Conditions
achalasia
Beyond the preview
Go deeper on NCT05550194.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05550194.